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The present study examines the kinetics of arachidonic acid (AA) metabolism
by murine macrophages isolated from sites of experimentally induced pulmo-
nary granulomatous inflammation. Macrophages of T-cell-mediated hypersen-
sitivity lesions induced by Schistosoma mansoni eggs (SE-GM) and non-T-cell-
mediated foreign-body-type lesions (FB-GM) induced by Sephadex beads were
examined. Overall, macrophages from both types of lesions produced mainly
lipoxygenase pathway metabolites, leukotrienes, and monohydroxyeicosa-
tetraenoic acids (mono-HETEs). Early after induction (4 days [4DJ), SE-GM
showed an augmented zymosan-stimulated AA release and metabolism com-
pared to resident peritoneal macrophages. Macrophages from mature lesions
(8-32D) showed constitutive synthesis of metabolites and were refractory to
zymosan stimulation. Both SE-GM and FB-GM showed augmented AA uptake
incorporating a large proportion into neutral lipids. A direct comparison of SE-
GM and FB-GM revealed that the T-cell-mediated lesion produced lesser
amounts of prostaglandins and leukotrienes and showed reduced incorpora-
tion of AA into phosphatidylcholine. These data suggest that AA metabolism
by granuloma macrophages is sequentially modified during recruitment and
activation at sites of chronic inflammation.
Key words: macrophages, arachidonic acid, granuloma, leukotrienes, monohydrox-
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INTRODUCTION
Numerous in vitro studies have established the exquisite capacity of macro-
phages to metabolize arachidonic acid (AA) to a variety of biologically active corn-
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pounds [l-4J. These include products derived from lipoxygenase (LTs, HETEs) and
cyclooxygenase (PGs) enzyme systems. Previous studies of Scott et al 15] and Humes
et at [6] showed that mouse macrophage metabolic capacity is dependent on their state
of activation such that there is diminished AA metabolism in activated cells. The
significance of these findings with regard to macrophage inflammatory function is not
known. Moreover, few studies have defined the sequential changes in macrophage
AA metabolism occurring at sites of chronic inflammation.
In the present study, we examined AA metabolism by murine macrophages
isolated from synchronously developing puylmonary granulomas induced by Schisto-
soma mansoni eggs (SE-GM) or Sephadex beads (FB-GM). The former represents a
T-cell-mediated hypersensitivity-type lesion under regulation of T helper and suppres-
sor cell subsets [7,8]. The latter is a foreign-body-type lesion without antigen-specific
T-cell involvement. Thus, we determined sequential changes in AA metabolism of
macrophages at sites of chronic inflammation recruited under contrasting conditions.
Our results showed time-dependent changes in macrophage AA metabolism as
granulomas matured and resolved. Overall, the macrophages produced predominantly
lipoxygenase-derived metabolites. Zymosan-stimulated macrophages from early le-
sions (4 days) showed an augmented release of the products compared to resident
peritoneal macrophages. Those from mature lesions (8-32D) synthesized these prod-
ucts constitutively and were unresponsive to phagocytic stimuli. Granuloma macro-
phages also showed greater incorporation of AA with a large proportion found in
neutral lipids. When provided with exogenous AA, macrophages from non-T-cell
lesions produced greater amounts of LTs and PGs compared to those of T-cell-
mediated lesions, which produced primarily HETEs. Also, macrophages from T-cell
lesions showed less incorporation of fatty acid (AA and oleic acid) into phosphatidyl-
choline. These findings suggest that AA metabolism by granuloma macrophages is




Pathogen-free female CBA/J mice (The Jackson Laboratory, Bar Harbor, ME)
were used throughout this study. The mice were maintained under standard care and
given food and water ad libitum.
Induction of Pulmonary Granulomas
Eggs were isolated aseptically from the livers of mice previously infected with
200 cercariae of Schistosoma mansoni by the method of Coker and von Lichtenberg
[9]. The isolated schistosome eggs were suspended to 6,000 eggs/ml sterile physio-
logical saline and each mouse received 3,000 eggs via tail vein injection. Sephadex
beads (G-200 superfine, Pharmacia, Uppsala, Sweden) were swollen in saline and
sized with nylon mesh to remove particles less than 40 .tm in diameter. The slurry
was autoclaved and then suspended to 10,000 beads/mi of sterile saline. Each mouse
received 5,000 beads by tail vein injection as above.
Isolation and Culture of Granuloma Macrophages
Dispersed granuloma cells were obtained from schistosome egg or Sephadex
bead-induced lung granulomas by a modification of the procedure of Moore et al
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[10]. At 4, 8, 16, or 32 days postembolization mice were sacrificed and granulomatous
lungs were inflated with 1 ml cold RPMI-l640, excised, and homogenized for 20 sec
at low speed in a commercial Waring blender. Granulomas were then collected and
rinsed free of adherent blood, single cells, and parenchyma over a stainless steel
mesh. Granulomas were washed three times in RPMI, pelleted in a 50-mi plastic
centrifuge tube (Corning Glass Works, Corning, NY), and resuspended in three
volumes of sterile digestion medium consisting of RPMI containing 10% fetal bovine
serum (FBS) (KC Biological, Inc., Lenexa, KS), 10 mM HEPES buffer, 2,000 U/mt
Type II collagenase (Sigma Chemical Co., St. Louis, MO), and 20 g/ml gentamicin
(Schering Pharmaceutical Corp., Kenilworth, NJ). The dispersed cells were then
vigorously agitated for 30 mm in a 37#{176}Cwater bath. The suspension was passed
through a #100 steel mesh and collected by centrifugation. The resuspended cells
were strained through a 50-/Lm nylon sieve to remove nondispersed cells and partic-
ulates. Granuloma cells were washed twice, centrifuged, counted, and resuspended
in RPM! containing 10% FBS and 20 /Lg/ml gentamicin. Two milliliters of granuloma
cells (2 x 106 cells/mI) were allowed to adhere to 60-mm plastic culture dishes
(Corning Glass Works) overnight at 37#{176}Cin a 5% CO2. humidified atmosphere.
Nonadherent cells were removed by at least two vigorous rinses with warm serum-
free medium. The number of adherent cells was quantitated by direct counting of
Wright-stained monolayers. These cells are routinely >90% macrophages by mor-
phological criteria, phagocytosis of inert beads, and staining for nonspecific esterase
[11].
In some experiments resident peritoneal macrophages were used as control cells
and were obtained by the standard method of peritoneal lavage with sterile RPMI
medium. Collagenase treatment of suspended peritoneal macrophages had no effect
on their capacity to metabolize arachidonic acid.
Determination of Pulmonary Granuloma Area
Mice were sacrificed at 4, 8, 16, and 32 days postegg challenge and the lungs
were inflated with 10% buffered formalin, excised, and prepared for histologic
section. The pulmonary granuloma areas were measured from hematoxylin and eosin
stained sections using an Omicron Alpha Image Analyzer (Bausch and Lomb, Roch-
ester, NY) interfaced with an attached computer. A minimum of 20 granulomas were




The washed macrophage monolayers (60-mm dishes) were overlaid with 2.0 ml
of serum-free RPMI containing 1 jzCi of 3[H]arachidonic acid (3[H]AA) (New
England Nuclear, Boston, MA, specific activity = 91 Ci/mmol). After a 4-hr
incubation at 37#{176}C,the media were discarded and monolayers were washed twice
with prewarmed RPM! to remove unincorporated 3[HIAA. Two milliliters of fresh
RPMI was added and the cells were incubated for another 45 mm with or without
opsonized zymosan (500 /Lg). In some experiments monolayers were simply overlaid
with 3[H]AA medium and accumulated metabolites were measured at 6, 12, and
18 hr.
Arachidonic acid metabolites were extracted as previously described [12]. Me-
dia and monolayers were collected after incubation, acidified to pH 3.0 with 1 N
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HC1, then extracted twice with three volumes of ethyl acetate. This procedure gave
greater than 90% recovery of all AA metabolite standards. The solvent was vaporized
under vacuum using a Speed Vac Concentrator (Savant Instruments, Inc. , Westbury,
NY). Extracts were stored under 100% N2 at -20#{176}C and then dissolved in 0. 1 ml
absolute methanol just before column chromatography. Metabolites of 3[H]AA were
identified by reverse-phase high-performance liquid chromatography (HPLC) utiliz-
ing two solvent systems. In method I, 0. i-mI samples were applied to a 5-rim C-l8
(30 x .4-cm) column (Varian, Palo Alto, CA) at 29#{176}Cwith a 1-mI /min flow rate.
The solvent, acetonitrile (Burdick Jackson, Muskegon, MI)/water/trifluoroacetic acid
(pH 2.0) (Pierce Chemical Co., Rockford, IL), was used as follows: the first 40 mm
were isocratic (31:69:0.1, vol/vol/vol) followed by a linear gradient increase of
acetonitrile starting at 45:55:0.1 to 65:35:0.1 over a 2-hr period. Finally the column
was washed for 30 mm at 100:0:0.1. In method II, a 3-j.tm C-18 column (Varian) was
used under similar conditions but the solvents were run as follows: isocratic for 35
mm (33:67:0.1), then a linear gradient from 45:55:0.1 to 55:45:01 over 1 hr, then a
second 10-mm gradient from 55:45:01 to 80:20:01, and finally 100:0:0. 1 to remove
AA and wash the column. The eluates were continuously monitored for UV absorb-
ance using a variable wavelength detector (280 and 235 nm). In addition, radioactivity
was measured in an in-line radioactive monitor (Radiomatic Instruments & Chemical
Co. Inc., Westshore, FL) and a flow ratio of 5:1 (aqueous scintillant [Radiomatic,
Tampa, FL] to sample) was used. Characteristic ultraviolet spectra of leukotrienes
and mono-HETEs were determined with a Carey 210 spectrophotometer and com-
pared with known standards.
The columns were calibrated using radiolabeled and unlabeled standards.
Thromboxane B2, prostaglandins E2, F2,,, and D2, as well as 5- and 12-HETE were
kindly provided by Drs. John Pike and Robert Gorman (The Upjohn Co., Kalamazoo,
MI). Unlabeled leukotrienes were the generous gifts of Dr. J. Rokach (Merck-Frosst
Laboratories, Quebec, Canada). Carbon-i4-labeled LTB4 was provided by Henry
Showell (Pfizer, Central Research, Groton, CT). Tritiated LTC4, ‘4[C]oleic acid, and
3[H]AA were purchased from New England Nuclear. Fifteen-HPETE and 15-HETE
were prepared using soybean lipoxygenase (Sigma) as described [13]. In some cases
unlabeled standards were added to samples to act as internal markers.
Determination of AA Incorporation Into Membrane Phospholipids
At designated intervals following exposure to 3[H]AA, granuloma macrophage
monolayers were washed twice with warm RPMI and then placed on ice. The cells
were then scraped from the dishes using a rubber policeman and quantitated. Cells
were pelleted by centrifugation and dissolved in chloroform (4 ml)-methanol (1 ml).
After a 15-mm incubation at room temperature, 1.25 ml of 5% KC1 solution was
added and the mixture was vortexed for 30 see, then centrifuged (500g. 5 mm). The
organic layer was collected and vaporized under N2. The residue was then analyzed
for lipids by silica gel thin-layer chromatography (TLC) (EM reagents, Darmstadt,
Germany) with a two solvent system as follows: 1) chloroform-methanol acetic acid
(100 ml CHCI3, 60 ml CH3OH, 16 ml glacial acetic acid, 8 ml H2O), followed by 2)
petroleum ether-ethyl ether (78:22). Pure lipid standards served as markers (Supelco,
Inc., Belefonte, PA). Potassium iodide was used to stain and localize the separated
lipids.
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Statistical Analysis
The Student’s t-test was used to analyze control and experimental groups where
applicable. Values of p > .05 were considered not significant.
RESULTS
Spontaneous Metabolism of AA by Granuloma Macrophage Populations
Initially, we wished to determine the profile of metabolites spontaneously re-
leased by granuloma macrophages. In these experiments macrophage cultures were
prelabeled with 1.0 Ci of 3[H]AA for 4 hr, then washed and allowed to incubate a
further 45 mm. Following incubation, cultures were extracted and analyzed by HPLC
as described in Materials and Methods. As shown in Figure 1, time-dependent
changes were observed in SE-GM. At day 4 the major products were free AA and a
single mono-HETE that comigrated with the 12-HETE standard. At days 8 and 16 a








Fig. I. Spontaneous release of arachidonic acid metabolites by macrophages from S. mansoni egg
(hypersensitivity-type) granulomas at sequential stages of development. Macrophage cultures were
prelabeled (4 hr) with 1 Ci 3lHlarachidonic acid, washed, incubated an additional 45 mm, then extracted
for HPLC analysis (method I). Total cpm of the material was normalized to 1 x l0 cells and replotted.
There was no statistical difference in AA uptake by macrophages at the indicated time points. Chroma-








676 Chensue et al







40 80 120 160 40 80 120 160
ELUTION VOLUME (ml)
Fig. 2. Spontaneous release of arachidonic acid metabolites by resident peritoneal and l6D Sephadex
bead (foreign-body-type) granuloma macrophages. Cultures and extractions were prepared as described
for Figure 1. Uptake of AA by resident macrophages was approximately 50% of that for bead granuloma
macrophages.
detected. By day 32, when the lesion was resolving, there was a notable reduction in
HETEs and free AA but a persistence of material in the LT region.
We likewise examined the products released spontaneously by resident perito-
neal and FB-GM macrophages (Fig. 2). As previously reported, unstimulated resident
macrophage produced barely detectable amounts of material [5,12]. However, l6D
FB-GM gave a pattern similar to that obtained with the 32D SE-GM.
Effect of Exogenous Stimuli on Granuloma Macrophage
AA Release and Metabolism
We next determined the products released by granuloma macrophages following
stimulus with opsonized zymosan. Figure 3 shows the zymosan-induced AA release
response of SE-GM compared to that of resident peritoneal macrophages. On a
percent basis, there was a steady decline in AA release as the granuloma reached
maximal size (day 16) (compare upper and central panels). However, examination of
the total counts per minute (CPM) of AA released showed this effect was due to an
increase in the spontaneous release of AA (lower panel). At day 4 there was actually
a dramatic augmentation of the total amount of released AA, which declined signifi-
cantly by day 8 and reached a minimum by day 32.
Analysis of the AA metabolites produced by SE-GM in response to zymosan
gave results similar to that observed with AA release (Fig. 4). The spontaneous
synthesis of LTs increased to a maximum at day 16 and was unchanged thereafter.
Mono-HETE production reached a maximum at day 8 and declined as the lesion
resolved (day 32). In contrast, the zymosan-induced release of these products was
greatest at day 4 with little or no significant incremental synthesis thereafter.
Thus, SE-GM early in development showed an augmented AA release and
metabolism in response to zymosan compared to resident peritoneal macrophages,
4
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Fig. 3. Zymosan-induced arachidonic acid release from schistosome egg granuloma macrophages
during sequential stages of lesion development. Percent AA release (upper panel) of resident and
‘chistosome egg granuloma macrophages. Granuloma size (middle panel) determined from groups of
five mice. Total cpm of AA recovered by HPLC from unstimulated (#{149}-#{149}) and zymosan-stimulated
#{149}---#{149})cultures (lower panel). Cultures were labeled with 1 /ACi of 3IH1AA for 4 hr. washed, then
stimulated 45 mm with opsonized zymosan. Normal mouse resident (R) peritoneal macrophages served
as a control. AA release values were derived from 3 to 4 separate experiments.
while macrophages of more mature lesions showed a constitutive release of significant
amounts of AA metabolites, but they had blunted responses to a phagocytic stimulus.
An examination of FB-GM also revealed blunted responses to zymosan. Figure
5 compares the HPLC profiles of the AA metabolites produced by resident peritoneal
and 16D FB-GM in the presence or absence of zymosan. The spontaneous release of
AA and the major metabolite, mono-HETE, was 10-30-fold greater for macrophages
from bead lesions. Upon stimulation with zymosan, resident macrophages showed a
200% increase in AA release with synthesis of two major metabolites, PGE2 and
LTC4, as reported by others [14]. In contrast, the FB-GM showed only a 40%
increase in AA release with little increase in other metabolites.
The above results suggested that macrophages at mature (8-32D) hypersensitiv-
ity or foreign-body-type granulomas begin constitutive release of AA and its metabo-
lites, but they show little or no incremental synthesis with further stimulation.
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Fig. 4. Zymosan-induced release of leukotrienes and mono-HETEs from schistosome egg granuloma
macrophages during sequential stages of development. Macrophage cultures were labeled with I Ci of
3IHIAA for 4 hr. washed, then incubated for 45 mm with or without zymosan. Extracted cultures were
analyzed by HPLC (method I) and the total cpm of recovered products were determined and normalized
to cell number. Bars show the mean ± SE of 3 to 4 separate experiments. Values of resident peritoneal
cultures (RES) are shown for comparison.
Metabolism of Exogenous AA by Granuloma Macrophages
We next compared the capacity of SE-GM and FB-GM to metabolize exoge-
nously provided AA. In these experiments macrophage monolayers were overlaid
with serum-free medma containing 1.0 pCi 3[H]AA; then at designated intervals the
cultures were extracted and analyzed for the presence of metabolites. Figure 6 shows
the results of these experiments. The exogenously supplied AA was converted to
essentially the same major products seen in the shorter 45-mm cultures but in greater
quantities. Over an 18-hr period, 16D FB-GM synthesized greater amounts of PG and
LT from exogenously supplied AA compared to 16D SE-GM. The total quantity of
mono-HETEs produced was comparable among the groups, but there was a tendency
for macrophages from egg lesions to make more mono-HETEs. These differences
were enhanced by providing larger amounts (5 ptCi) of 3[H]AA as shown in the
HPLC chromatograms (Fig. 7). As before, macrophages from Sephadex bead lesions
produced more PGs and LTs and significantly less mono-HETEs than those of
hypersensitivity egg lesions.
By adding unlabeled AA (5 jIM), enough material was obtained for spectropho-
tometric analysis of the products (Fig. 8). Two peaks (the major one at 54-59 mm
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Fig. 5. Zymosan-induced release of arachidonic acid metabolites by resident peritoneal and Sephadex
bead (foreign-body-type) granuloma macrophages. Cultures were prelabeled for 4 hr with I tCi of
3IHIAA, washed, then incubated for 45 mm with or without zymosan. Extracted cultures were analyzed
by HPLC (method I). Chromatograms were derived from two separate experiments.
and a smaller one at 60-65 mm) showed characteristic absorbance spectra for SRS-A
and LTB4 conjugated trienes, with peak absorbances at 279 and 270 nm, respectively.
Likewise, the putative mono-HETE peaks (80-95 mm) showed characteristic peak
absorbance at 235 nm.
Uptake and Phospholipid Distribution of AA in Granuloma Macrophages
In view of the changes observed in AA metabolism by granuloma macrophages,
it was important to establish the intracellular fate of exogenously supplied AA. Figure
9 compares the uptake of AA by granuloma and resident peritoneal macrophages. A
nearly twofold greater amount of AA was incorporated by both the SE- and FB-GM.
This is in accord with previous reports demonstrating enhanced AA incorporation by
recruited macrophage populations [2].
Using thin-layer chromatography, the distribution of 3[H]AA among membrane
lipids was determined (Fig. 10). Among granuloma macrophages, up to 60% of the
incorporated label was found in neutral lipids (NL), 25-30% in phosphatidylcholine
(PC), and the remainder in phosphatidylinositol (P1), phosphatidylserine (PS), and
phosphatidylethanolamine (PE). In contrast, in resident peritoneal macrophages,
greater than 80% of the label was in PC and other phospholipids with only 15% in
NL. Thus, while granuloma macrophages incorporated greater quantities of AA, the
bulk of this was placed into neutral lipid pools. Essentially, identical results were
obtained when cells were labeled in the presence of albumin (data not shown).
Figure 10 also shows that compared to the other populations, SE-GM had
consistently less AA present in PC (p < .01). Moreover, we could demonstrate loss
of AA from PC, P1, and PS when cells were stimulated with zymosan. An approxi-











0 6 12 18
HOURS
Fig. 6. Kinetics of arachidonic acid metabolism by macrophages from 16D schistosome egg and
Sephadex bead granulomas. Macrophage cultures were overlaid with medium containing I jCi of
3IHIAA and then extracted at 6, 12, and 18 hr of incubation. Accumulation products were determined
by HPLC (method I) and then normalized to cell numbers. Values were derived from two separate
experiments. A, schistosome egg; #{149},Sephadex bead.
mately 50% loss was shown for residents, but there was only a 20% loss for 16D
granutoma macrophages (no figure). When we likewise examined the distribution of
another fatty acid, ‘4C-labeled oleic acid, both resident and SE-GM showed compa-
rable uptake into NL (Fig. 11). However, the SE-GM again showed reduced incor-
poration into PC. Taken together, these data indicated that resident macrophages
preferentially placed AA into phospholipids. In contrast, SE-GM showed reduced
incorporation into PC with increased incorporation into NL. By the intensity of lipid
staining (Fig. 11), granuloma macrophages had increased amounts of triglycerides as
previously reported for other “recruited” macrophage populations [2]. Thus, the
increased incorporation into NL may in part be due to the increased triglyceride
pools.


















Fig. 7. Exogenous metabolism of arachidonic acid by Sephadex bead (FB-GM) and schistosome egg
(SE-GM) granuloma macrophages. Macrophage cultures were overlaid with 5 jzCi of 3EH1AA and then
extracted after 12 hr of culture. Representative HPLC chromatograms (method II) are shown with the






Fig. 8. Spectrophotometric analysis of granuloma macrophage arachidonic acid metabolites. Eight-day
schistosome egg granuloma macrophage cultures were overlaid with medium containing 5 cM unlabeled
AA and incubated for 12 hr. Following extraction, the metabolites were analyzed by HPLC (method II)
and the peaks were collected for spectrophotometric scanning. Material eluted from 54 to 59 mm (A),
60 to 65 mm (B). and 80 to 95 mm (C).
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Fig. 9. Uptake of arachidonic acid by resident peritoneal and granuloma (l6D) macrophage popula-
tions. Macrophage cultures were overlaid with I zCI 3IHIAA. At designated intervals monolayers were
washed, collected, solubilized in chloroform-methanol, and aliquots were measured for total radioactiv-






















Fig. 10. Distribution of arachidonic acid in membrane lipids of resident peritoneal and granuloma
(16D) macrophage populations. Macrophage cultures were labeled with I Ci 3IHIAA for 120 mm and
membrane lipids were then analyzed by TLC as described in Materials and Methods. Total radioactivity
was measured in iodine stained bands scraped from the plates. Bars represent the mean ± SE of three
experiments.
Fig. 11. Distribution of oleic and arachidonic acid in membrane lipids of resident peritoneal and
schistosome egg granuloma (16D) macrophages. Characteristic lipid chromatograms of resident perito-
neal and SE-GM are shown; the material was extracted from 360 X IO and 140 x l0 cells,
respectively. Despite less applied material, the SE-GM show more intense staining of neutral lipids. The
percent distribution of ‘4fCjoleic acid and 3IHIAA in major lipids is shown in the table.
The potential importance of AA metabolites in the induction and regulation of
inflammation has become increasingly apparent [15-18]. Thus, many investigators
have attempted to define their production and function at sites of inflammation in
order to aid the therapeutic manipulation of destructive inflammatory processes.
In the present study employing a model of synchronous murine pulmonary
granulomatous inflammation, we have defined the AA metabotites produced by
macrophages (thought to be important sources of these products and the major
component of granulomas) during the induction, maintenance, and resolution of these
chronic lesions. Our results show that granuloma macrophages (GM) actively metab-
olize AA into a variety of products but primarily those derived from lipoxygenases,
LTs, and HETEs. This is in accord with our previous study [12], which examined
hepatic granulomas during active murine schistosomiasis mansoni, as well as studies
of Humes et at and Bonta et al [19,20] with carrageenin-induced granulomas.
When compared to stimulated resident peritoneal macrophages, GM did not
produce significant amounts of PGs after 45 mm of culture. This finding agrees with
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previous reports of Humes et al [61 and Scott et al [5], which showed reduced PG
production by recruited or “activated” macrophages. It further supports the notion
that substrate availability or the activity of cycbooxygenase (CO) pathway enzymes is
“down-regulated” in activated macrophages. This also seems consistent with our
finding that FB-GM showed greater PG synthesis than hypersensitivity SE-GM,
which are thought to be more “activated” [1 1,21,22].
It is conceivable that down-regulation of PG synthesis may be an important
proinflammatory event. While PGs, especially of the E series, may have vasoactive
functions in early acute inflammatory events, they appear to suppress many inflam-
matory responses such as lymphocyte proliferation [15], lymphokine production [23],
granulocyte function [24], macrophage Ia antigen expression [21 , 25], and, as we
recently reported, interleukin-l production [26]. Thus, specific reduction in PG
synthesis by macrophages may help inflammatory events to proceed.
The predominance of lipoxygenase (LO)-derived AA metabolite synthesis by
GM is consistent with accumulating evidence showing their proinflammatory function
[27-29]. We reported that pharmacologic suppression of LO but not CO products
caused a significant reduction of granulomatous inflammation [30]. Likewise, others
have shown that carrageenin-induced granulomas were not affected by CO inhibitors
[31]. Hence, LO products may be important to the induction and maintenance of the
cellular infiltrate. One caveat should be added. Until the precise functions of the LO
products, especially the HETEs, have been better characterized, it will be difficult to
fully understand the significance of their presence at inflammatory sites.
Our finding showing augmented zymosan-induced release of AA and its metab-
olites by GM from early lesions followed by refractory responses in mature lesions
may indicate that macrophage AA metabolism is tailored to the specific phase of
inflammation. Teleologically, it seems appropriate that during the early recruitment
phase macrophages would be “primed” for maximal mediator release in response to
stimuli. Subsequently, these cells shift to constitutive production of these mediators
for maintenance of the lesion. This refractory state of “activated” macrophages has
been described in other systems and may reflect prior in vivo triggering followed by
metabolic modulation [5]. This modulation may be related to the release of macro-
phage-derived reactive oxygen intermediates (eg, Of), which we have recently shown
to become significant at day 8 and beyond [32]. It has been suggested that such
products may inactivate enzymes involved in AA metabolism [331. This could explain
the refractory state as well as the observed suppression of AA metabolism with
zymosan stimulation at day 8. Heretofore, this refractory state has seemed paradoxical
since “activated” cells were expected to show augmented responses to stimuli. Our
data suggest that this may in fact be true if macrophages are examined soon after
recruitment to inflammatory foci. Moreover, special attention must be paid to quan-
titating the spontaneous release and absolute amounts of products rather than only
percentage shifts.
Analysis of AA uptake and its distribution revealed notable differences between
resident and granuloma macrophage populations. As reported for other “activated”
macrophage populations [2], both the SE-GM and FB-GM showed enhanced incor-
poration of AA. Much of the additional incorporated AA was found in NL (triglyc-
erides/cholesterol esters). Examination of phospholipids showed that the total CPM
incorporated was comparable for resident and FB-GM, but there was significantly
reduced incorporation into PC by SE-GM. The latter finding and the above-mentioned
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reduction in PG and LT synthesis were the main characteristics of SE-GM distinguish-
ing them from FB-GM. Presumably, this difference is related to the presence of
antigen-specific T-celt factors present at SE but not FB granulomas. It is noteworthy
that at the resolution phase (32D), SE-GM AA metabolism appeared to revert to a
pattern resembling the FB-GM. Thus, as the antigenic stimulus of T cells “burns
out,” the lesion may become FB-like.
It is tempting to draw a relationship between the reduced LT/PG synthesis and
the decreased amounts of AA in phosphatidytcholine. At least two scenarios can be
constructed. 1) There is evidence that AA may be stored in different subcellular pools
that are linked to different enzyme systems [34,35]. Phosphatidylcholine may be the
primary reservoir of AA for LT and PG synthesis, whereas HETE may be derived
from additional AA poots, eg, other phospholipids and neutral lipids. Reduced
acylation of PC in “activated” SE-GM would thereby lead to reduced LT and PG
synthesis. 2) An alternative model is that our data reflect brisk phosphotipase A2
activity and reduced PG and LT synthesis in the face of active HETE synthesis.
Further studies are underway to distinguish these possibilities and to determine the
inter- and intracellular signals that modulate granuloma macrophage AA metabolism.
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